This study assessed the real-world effectiveness of available GLP-1 RAs in Romania on glycemic control, body weight reduction (BWR), and waist circumference (WC) in T2DM patients with excess weight. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.